On the positive side, the intricate co-evolution of LPS and AMPs provides valuable insights into resistance mechanisms, offering potential strategies to target the wide array of LPS structures and modifications. Targeting LPS can involve designing novel LPS-disrupting peptides or developing inhibitors for key LPS-editing pathways, such as the catalytic pockets of Mcr-1 and ArnT (Figure ).